Jacobs Levy Equity Management, Inc Gossamer Bio, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,091,564 shares of GOSS stock, worth $2.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,091,564
Previous 282,264
286.72%
Holding current value
$2.81 Million
Previous $310,000
332.9%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding GOSS
# of Institutions
136Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$47.2 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$46.5 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$29.3 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$20.7 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$18.4 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $241M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...